Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -765.53x is 366% below its 5-year average of -164.40x, near the low end of its 5-year range (-765.53x–-17.95x).
2143.21% below its 12-month average of -34.13x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -28.31x.
INTEREST COVERAGE RATIO
-765.53x
INTEREST COVERAGE RATIO AVG TTM
-34.13x
INTEREST COVERAGE RATIO AVG 3Y
-152.29x
INTEREST COVERAGE RATIO AVG 5Y
-164.40x
INTEREST COVERAGE RATIO AVG 10Y
-130.74x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-2143.21%
CURRENT VS 3Y AVG
-402.66%
CURRENT VS 5Y AVG
-365.66%
CURRENT VS 10Y AVG
-485.52%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-11787.11%
vs the sector median at left
CollPlant Biotechnologies Ltd.
Market Cap
$4.40M
Interest Coverage Ratio
-765.53x
TTM Avg
-34.13x
3Y Avg
-152.29x
5Y Avg
-164.40x
Market Cap
$4.32M
Interest Coverage Ratio
-21.32x
TTM Avg
128.62x
3Y Avg
128.62x
5Y Avg
128.62x
Market Cap
$4.53M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.55M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.21M
Interest Coverage Ratio
N/A
TTM Avg
11.42x
3Y Avg
11.42x
5Y Avg
7.97x
Market Cap
$4.69M
Interest Coverage Ratio
-16.26x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.72M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CollPlant Biotechnologies Ltd. (CLGN) | $4.40M | -765.53x | -34.13x | -152.29x | -164.40x |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -21.32x | 128.62x | 128.62x | 128.62x |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.53M | N/A | N/A | N/A | N/A |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | N/A | N/A | N/A | N/A |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.21M | N/A | 11.42x | 11.42x | 7.97x |
| GRI Bio, Inc. (GRI)vs › | $4.15M | N/A | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.69M | -16.26x | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $4.71M | N/A | 1.00x | 1.02x | 1.02x |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.72M | N/A | N/A | N/A | N/A |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.90M | -994.05x | N/A | N/A | N/A |
Interest Coverage
-765.5x
Debt/Equity
0.90
Current Ratio
1.57
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -28.31x |
| 2025-12-31 | -55.26x |
| 2025-06-30 | -18.80x |
| 2023-12-31 | -506.80x |
| 2023-03-31 | -17.95x |
| 2022-06-30 | -41.85x |
| 2022-03-31 | -40.96x |
| 2021-09-30 | -386.75x |
| 2021-06-30 | -382.88x |
| 2021-03-31 | 527.68x |
| 2020-12-31 | -104.35x |
| 2020-09-30 | 66.73x |
| 2020-06-30 | -956.50x |
| 2020-03-31 | -426.75x |
| 2019-09-30 | -1.26x |
| 2019-06-30 | -293.50x |
| 2019-03-31 | -3.12x |
| 2018-06-30 | -7.59x |
| 2018-03-31 | -17.44x |
| 2017-03-31 | -86.55x |
| 2015-09-30 | -342.93x |
| 2015-06-30 | -19.22x |
| 2015-03-31 | -189.11x |
| 2014-12-31 | -11.46x |
| 2014-09-30 | -95.03x |
